Related Experiment Videos
Telomerase inhibitors
L K White1, W E Wright, J W Shay
1Depts of Internal Medicine and Cell Biology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9039, USA.
Abstract:
There has been a vast increase in telomerase research over the past several years, with many different pre-clinical approaches being tested for inhibiting the activity of this enzyme as a novel therapeutic modality to treat malignancy. In this review, we will provide some basic background information about telomeres and telomerase and then discuss the pros, cons and challenges of the approaches that are currently under investigation, and what we might expect in the future of this emerging field.
Insights
Telomerase research is rapidly advancing, exploring enzyme inhibition as a novel cancer treatment. This review covers telomere and telomerase basics, current therapeutic approaches, and future prospects in oncology.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Telomeres protect chromosome ends, and their shortening is linked to cellular aging.
- Telomerase is an enzyme that maintains telomere length, often reactivated in cancer cells.
- Dysregulation of telomere maintenance is a hallmark of cancer, driving tumor progression.
Purpose of the Study:
- To provide a foundational understanding of telomeres and telomerase.
- To review current pre-clinical strategies for inhibiting telomerase activity.
- To discuss the potential and challenges of telomerase inhibitors as anti-cancer therapeutics.
Main Methods:
- Literature review of pre-clinical studies on telomerase inhibition.
- Analysis of various therapeutic approaches targeting telomerase.
- Discussion of future directions and potential clinical applications.
Main Results:
- Multiple pre-clinical strategies for telomerase inhibition are under investigation.
- Telomerase inhibitors show promise as a novel anti-cancer therapeutic modality.
- Significant challenges remain in developing effective and safe telomerase-targeting drugs.
Conclusions:
- Telomerase inhibition represents a promising area for cancer therapy development.
- Further research is needed to overcome challenges and translate pre-clinical findings into clinical success.
- The future of telomerase-targeted cancer treatment holds significant potential for improving patient outcomes.